Epinephrine Augments von Willebrand Factor‐Dependent Shear‐Induced Platelet Aggregation

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Circulation

• Publication date

  1992-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.86.6.1859PMID 1360339
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transmembrane Calcium Influx Associated with von Willebrand Factor Binding to GP Ib in the Initiation of Shear-Induced Platelet Aggregation

  1993cited by this paper
• Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib.

  1992cited by this paper
• Catecholamines and thrombocyte α2-adrenoceptors in patients with acute myocardial infarction

  1991cited by this paper
• Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.

  1991cited by this paper
• Catecholamines and thrombocyte alpha 2-adrenoceptors in patients with acute myocardial infarction.

  1991cited by this paper
• Studies on Anti-von Willebrand Factor (vWF) Monoclonal Antibody NMC-4, Which Inhibits Both Ristocetin- and Botrocetin-Induced vWF Binding to Platelet Glycoprotein Ib

  1991cited by this paper
• The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.

  1991cited by this paper
• Aurintricarboxylic acid in a canine model of coronary artery thrombosis.

  1990cited by this paper
• Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.

  1990cited by this paper
• Shear-induced platelet aggregation.

  1990cited by this paper
• Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.

  1989cited by this paper
• Continuous measurement of shear-induced platelet aggregation.

  1989cited by this paper
• Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.

  1989cited by this paper
• Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.

  1989cited by this paper
• Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.

  1988cited by this paper
• Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.

  1987cited by this paper
• Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa.

  1987cited by this paper
• Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.

  1987cited by this paper
• Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.

  1987cited by this paper
• Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease.

  1987cited by this paper
• Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.

  1986cited by this paper
• Potentiation with epinephrine of macaque platelet aggregation by other agonists: implications for studies on human atherosclerosis.

  1986cited by this paper
• Platelet activation by circulating levels of hormones: a possible link in coronary heart disease.

  1984cited by this paper
• Assay procedures for the determination of biogenic amines and their metabolites in rat hypothalamus using ion-pairing reversed-phase high-performance liquid chromatography.

  1983cited by this paper
• Blood Flow Reductions in Stenosed Canine Coronary Arteries: Vasospasm or Platelet Aggregation?

  1982cited by this paper
• The facilitating effects of adrenaline on platelet aggregation.

  1982cited by this paper
• The effect of PGI2 and theophylline on the response of platelets subjected to shear stress

  1981cited by this paper
• The effect of PGI2 and theophylline on the response of platelets subjected to shear stress.

  1981cited by this paper
• The effects of alpha adrenergic agents on human platelet aggregation.

  1979cited by this paper
• Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man.

  1977cited by this paper
• Effects of adrenaline on human blood platelets

  1967cited by this paper
• Influence of Catecholamines on Nucleotide-induced Platelet Aggregation

  1966cited by this paper

• Physical and Mechanobiological Basis of Biological Functions of Platelets

  2025cites this paper
• Overview of Venous Thromboembolism and Emerging Therapeutic Technologies Based on Nanocarriers-Mediated Drug Delivery Systems

  2024cites this paper
• Important Regulatory Roles of Erythrocytes on Platelet Adhesion to the von Willebrand Factor on the Wall Under Blood Flow Conditions.

  2021cites this paper
• Computer Simulation of Platelet Adhesion around Stent Struts in the Presence and Absence of Tissue Defects around Them

  2021cites this paper
• Important Physical Regulatory Roles of Erythrocytes on Platelet Adhesion Under Blood Flow Conditions.

  2021cites this paper
• Effects of imidazoline and nonimidazoline α-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets.

  2020cites this paper
• Acute responses of platelet count and ADP-induced platelet aggregation to different high intensity interval exercise modes

  2020cites this paper
• Acute exercise-induced changes in hemostatic and fibrinolytic properties: analogies, similarities, and differences between normotensive subjects and patients with essential hypertension

  2019cites this paper
• Znaczenie adrenaliny w mechanizmie aktywacji ludzkich płytek krwi

  2019cites this paper
• Epinephrine restores platelet functions inhibited by ticagrelor: A mechanistic approach.

  2019cites this paper
• Effects of Repeated Bouts of Exercise on the Hemostatic System

  2018cites this paper
• Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents

  2018cites this paper
• Platelet activation and function in response to high intensity interval exercise and moderate continuous exercise in CABG and PCI patients

  2016cites this paper
• Prediction of Molecular Interaction between Platelet Glycoprotein Ibα and von Willebrand Factor using Molecular Dynamics Simulations.

  2016cites this paper
• Effects of Imidazoline and Nonimidazoline α2-Adrenergic Agents on Intracellular Cyclic AMP and Thromboxane B2 Concentrations in Canine and Leporine Platelets

  2015cites this paper
• Platelets: Small in Size But Essential in the Regulation of Vascular Homeostasis - Translation From Basic Science to Clinical Medicine.

  2015cites this paper
• Origin of Typical Disease Sequelae

  2015cites this paper
• What is the meaning of P2Y12 reaction units in patients with essential thrombocythemia?

  2015cites this paper
• Relationship between physiological function and metabolism of platelet cell

  2014cites this paper
• Association between sympathetic response, neurogenic cardiomyopathy, and venous thromboembolization in patients with primary subarachnoid hemorrhage

  2013cites this paper
• High on-treatment platelet reactivity – definition and measurement

  2013cites this paper
• Influence of training on markers of platelet activation in response to a bout of heavy resistance exercise

  2013cites this paper
• Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets.

  2013cites this paper
• Effects of Imidazoline and Non-Imidazoline α-Adrenergic Agents on Rabbit Platelet Aggregation

  2013cites this paper
• High on-treatment platelet reactivity (HPR): What does it mean, and does it matter?

  2013cites this paper
• Blockade of platelet alpha2B-adrenergic receptors: a novel antiaggregant mechanism.

  2013cites this paper
• Antithrombotic Therapy for Prevention of Various Thrombotic Diseases

  2013cites this paper
• Genetic Ablation of Adamts13 Gene Dramatically Accelerates the Formation of Early Atherosclerosis in a Murine Model

  2012cites this paper
• of procoagulant containing microparticles High shear stress can initiate both platelet aggregation and shedding

  2011cites this paper
• The Influence of Resistance Training on Primary Hemostatic Responses

  2011cites this paper
• Aerobic Training Restores Arterial Baroreflex Sensitivity in Older Adults With Type 2 Diabetes, Hypertension, and Hypercholesterolemia

  2010cites this paper
• Pronounced platelet hyperfunction in patients with cardiac arrest achieving restoration of spontaneous circulation*

  2009cites this paper
• The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease

  2008cites this paper
• Platelet Procoagulant Activity Appeared by Exposure of Platelets to Blood Flow Conditions

  2008cites this paper
• Epidemiology, Major Outcomes, Risk Factors, Prevention and Management of Chronic Kidney Disease in China

  2007cites this paper
• [Pharmacological properties of a specific Gq/11 inhibitor, YM-254890].

  2006cites this paper
• 特異的Gq/11阻害薬（YM-254890）の薬理学的プロファイル

  2006cites this paper
• Biological properties of a specific Gαq/11 inhibitor, YM‐254890, on platelet functions and thrombus formation under high‐shear stress

  2006cites this paper
• Na,K-ATPase inhibitors in hypertension

  2006cites this paper
• Exercise prescription and thrombogenesis.

  2006cites this paper
• Specific inhibiting effects of Ilexonin A on von Willebrand factor-dependent platelet aggregation under high shear rate.

  2004cites this paper
• Inherited bleeding disorders: disorders of platelet adhesion and aggregation.

  2004cites this paper
• Propagation of arterial thrombi: local and remote contributory factors.

  2004cites this paper
• Intense exercise increases shear-induced platelet aggregation in men through enhancement of von Willbrand factor binding, glycoprotein IIb/IIIa activation, and P-selectin expression on platelets

  2004cites this paper
• Effects of Exercise Training and Deconditioning on Platelet Aggregation Induced by Alternating Shear Stress in Men

  2004cites this paper
• Blood clotting in space.

  2004cites this paper
• Platelets and von Willebrand factor.

  2003cites this paper
• Increased platelet aggregation and production of platelet-derived microparticles after surgery for upper gastrointestinal malignancy.

  2003cites this paper
• Timing of anti-platelet effect after oral aspirin administration in patients with sympathetic excitement.

  2003cites this paper
• Different effects of various anti‐GPIIb‐IIIa agents on shear‐induced platelet activation and expression of procoagulant activity

  2003cites this paper
• Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.

  2002cites this paper
• Shear-induced von Willebrand factor-mediated platelet surface translocation of the CD40 ligand.

  2002cites this paper
• Shear‐induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis

  2002cites this paper
• Platelet aggregability under shear is enhanced in patients with unstable angina pectoris who developed acute myocardial infarction.

  2001cites this paper
• Influence of the ABO Blood Type on the Platelet Function Analyzer PFA-100

  2001cites this paper
• Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates.

  2001cites this paper
• Activation of the 2A –adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro

  2001cites this paper
• Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.

  2001cites this paper
• Enhanced shear-induced von Willebrand factor binding to platelets in acute myocardial infarction.

  2000cites this paper
• Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.

  2000cites this paper
• Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine.

  2000cites this paper
• 血流下のvon Willebrand factor依存性血栓形成機構

  2000cites this paper
• ACTIONS OF ALCOHOL AND ISCHAEMIC BRAIN INFARCTION

  2000cites this paper
• AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes.

  1999cites this paper
• A Sudden Increase in Plasma Epinephrine Levels Transiently Enhances Platelet Deposition on Severely Damaged Arterial Wall

  1999influential citation
• Effects of Imidazoline and Non-Imidazoline α-Adrenergic Agents on Canine Platelet Aggregation

  1999cites this paper
• Norepinephrine, but not epinephrine, enhances platelet reactivity and coagulation after exercise in humans.

  1999cites this paper
• Enhanced shear-induced platelet aggregation in acute myocardial infarction.

  1999cites this paper
• Effect of Plasma Protein on Shear-Induced von Willebrand Factor-Mediated Platelet Aggregation

  1999cites this paper
• Inhibitory Effects of Ifenprodil Tartrate on Platelet Aggregation as Measuerd by the Particle Counting Method Using Light Scattering and Shear-Induced Platelet Aggregometer

  1999cites this paper
• Functional compensation of the low platelet count by increased individual platelet size in a patient with May-Hegglin anomaly presenting with acute myocardial infarction.

  1998cites this paper
• Plasma von Willebrand Factor in Patients with Acute Myocardial Infarction

  1998cites this paper
• Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.

  1998cites this paper
• Genetic risk factors for coronary artery disease

  1998cites this paper
• Genetic Polymorphisms and Thrombotic Disorders

  1997cites this paper
• Von Willebrand Factor‐Dependent Shear‐Induced Platelet Aggregation: Basic Mechanisms and Clinical Implications

  1997cites this paper
• Calpain activation in shear‐induced platelet aggregation

  1997cites this paper
• New Antiplatelet Strategies in the Adjunctive Treatment of Acute Myocardial Infarction

  1997cites this paper
• Acute myocardial infarction plasma augments platelet thrombus growth in high shear rates.

  1997cites this paper
• High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles.

  1996cites this paper
• Epinephrine and Shear Stress Synergistically Induce Platelet Aggregation via a Mechanism That Partially Bypasses vWF-Gp Ib Interactions

  1996cites this paper
• Role of catecholamines in platelet function: pathophysiological and clinical significance

  1996cites this paper
• Epinephrine Augments Platelet Recruitment to Immobilized Collagen in Flowing Blood - Evidence for a von Willebrand Factor-mediated Mechanism

  1996cites this paper
• Biochemical characterization of a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venom.

  1996cites this paper
• Platelets and shear stress.

  1996cites this paper
• Enhanced Platelet Aggregability under High Shear Stress after Treadmill Exercise in Patients with Effort Angina

  1996cites this paper
• Synergistic effect of epinephrine and shearing on platelet activation.

  1996cites this paper
• Platelets and platelet inhibitors in acute myocardial infarction.

  1995cites this paper
• Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation.

  1995cites this paper
• Isolation and Characterization of jararaca GPIb-BP, a Snake Venom Antagonist Specific to Platelet Glycoprotein lb

  1995influential citation
• Protein Tyrosine Phosphorylation in Human Platelets during Shear Stress-Induced Platelet Aggregation (SIPA) Is Regulated by Glycoprotein (GP) Ib/IX as well as GP IIb/IIIa and Requires Intact Cytoskeleton and Endogenous ADP

  1995cites this paper
• Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress.

  1995cites this paper
• Epinephrine induces a late thromboxane-dependent platelet shape change and enhances synergistically the shape change induced by other platelet agonists.

  1995cites this paper
• Characterization of the Unique Mechanism Mediating the Shear-dependent Binding of Soluble von Willebrand Factor to Platelets (*)

  1995cites this paper
• Shear-dependence of endothelial functions

  1994cites this paper
• Heparin for unstable angina.

  1993cites this paper